FDA has amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the spike protein from the SARS-CoV-2 omicron variant lineage XBB.1.5.

That's a lot of letters but, just like the flu, if you have one of the big five co-morbidities, get it.

If you never had the prior vaccine, this will be two shots, three weeks apart.